Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.

Literature DB >> 32376597

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.

Achille Aouba¹, Aurelie Baldolli², Loïk Geffray³, Renaud Verdon², Emmanuel Bergot⁴, Nicolas Martin-Silva⁵, Aurélien Justet⁴.

Abstract

Entities: Disease

Keywords: antirheumatic agents; biological therapy; cytokines; interleukin 1 receptor antagonist protein; therapeutics

Year: 2020 PMID： 32376597 DOI： 10.1136/annrheumdis-2020-217706

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

Keyword Cloud
Cited

× No keyword cloud information.

90 in total

Review 1. COVID-19 Treatment at a Glance.

Authors: Hüseyin Arıkan; Dilek Karadoğan; Fatma Tokgöz Akyıl; Aycan Yüksel; Zehra Nur Töreyin; Canan Gündüz Gürkan; Feride Marim; Tuğba Şişmanlar Eyüboğlu; Nagehan Emiralioğlu; Tuğba Ramaslı Gürsoy; İrem Şerifoğlu; Abdulsamet Sandal; Aslı Öncel; Berrin Er; Neslihan Köse; Dorina Esendağlı; Mina Hızal; Aslıhan Banu Er; Fatma Esra Günaydın; İlknur Kaya; Hilal Özakıncı; Ümran Özden Sertçelik; Hatice Çelik Tuğlu; Nilüfer Aylin Acet Özürk; Özlem Ataoğlu; Ahu Cerit Çakır; Hüseyin Toptay; Merve Erçelik; Elif Develi; Selman Çelik; Fatma Gülsüm Karakaş; Halime Yıldırım; Damla Karadeniz Güven; Nazlı Çetin; Sümeyye Nur Aslan Küçükyurt; Mehmet Fatih Elverişli; Pinar Yıldız Gülhan; Metin Akgün
Journal: Turk Thorac J Date: 2020-11-01

2. A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics.

Authors: Amit Lakhanpal; Ernest Brahn
Journal: Eur J Rheumatol Date: 2020-05-22

3. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.

Authors: Pui Y Lee; Megan Day-Lewis; Lauren A Henderson; Kevin G Friedman; Jeffrey Lo; Jordan E Roberts; Mindy S Lo; Craig D Platt; Janet Chou; Kacie J Hoyt; Annette L Baker; Tina M Banzon; Margaret H Chang; Ezra Cohen; Sarah D de Ferranti; Audrey Dionne; Saddiq Habiballah; Olha Halyabar; Jonathan S Hausmann; Melissa M Hazen; Erin Janssen; Esra Meidan; Ryan W Nelson; Alan A Nguyen; Robert P Sundel; Fatma Dedeoglu; Peter A Nigrovic; Jane W Newburger; Mary Beth F Son
Journal: J Clin Invest Date: 2020-11-02 Impact factor: 14.808

4. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report.

Authors: Daniel Nan; Cristina Abraira-Meriel; Sandra de la Roz-Fernández; Tamara Maestre-Orozco; Jose Luis Hernandez; Marta Fernandez-Ayala
Journal: Eur J Case Rep Intern Med Date: 2021-10-08

Review 5. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

Authors: Isabelle Amigues; Alexander H Pearlman; Aarat Patel; Pankti Reid; Philip C Robinson; Rashmi Sinha; Alfred Hj Kim; Taryn Youngstein; Arundathi Jayatilleke; Maximilian Konig
Journal: Expert Rev Clin Immunol Date: 2020-11-25 Impact factor: 4.473

6. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.

Authors: Lauren A Henderson; Scott W Canna; Kevin G Friedman; Mark Gorelik; Sivia K Lapidus; Hamid Bassiri; Edward M Behrens; Anne Ferris; Kate F Kernan; Grant S Schulert; Philip Seo; Mary Beth F Son; Adriana H Tremoulet; Rae S M Yeung; Amy S Mudano; Amy S Turner; David R Karp; Jay J Mehta
Journal: Arthritis Rheumatol Date: 2021-02-15 Impact factor: 10.995

Targeting the inflammatory cascade with anakinra in moderate to severe COVID-19 pneumonia: case series.

Review 1. COVID-19 Treatment at a Glance.

2. A perspective on modern advances for COVID-19 (SARS-CoV-2) therapeutics.

3. Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children.

4. Delayed Use of the Recombinant Human IL-1 Receptor Antagonist Anakinra in Five COVID-19 Patients with Pulmonary Fibrosis and Persistent Hypoxaemia: A Preliminary Report.

Review 5. Coronavirus disease 2019: investigational therapies in the prevention and treatment of hyperinflammation.

6. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.

Review 7. Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents.

Review 8. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.

9. Quality and consistency of clinical practice guidelines for treating children with COVID-19.

Review 10. Promising Immunotherapies against COVID-19.